TOP NEWS

Blacksmith Medicines Gets Seed Funding

San Diego-based Blacksmith Medicines, a new biotechnology company focused on creating medicines for immuno-oncology and inflammatory diseases by targeting human metalloenzymes, has raised a round of seed funding, and announced a research deal with Lilly. Financial details of that seed funding were not announced. The company--a spin-out of For

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.